Report an error

Spotted something inaccurate in “Oral GLP-1 Drug Delivers Up to 12% Weight Loss in Phase 2 Trial Without Injection Requirements”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.